Authorities have released new images of a person of interest in the Brown University shooting, focusing on a stocky man last seen near campus. Could this be the breakthrough they need?
In a heartfelt announcement, the family of bestselling author Sophie Kinsella reveals her passing at 55 after battling brain cancer. Remembered for her iconic Shopaholic series, her legacy will live on in the hearts of millions.
A powerful winter storm has wreaked havoc across the Midwest, causing a 45-car pile-up in Indiana and a Delta flight to skid off a runway in Iowa. With millions under weather alerts and over 4,200 flights delayed, travel woes are hitting hard this Thanksgiving weekend.
Three Austrian nuns in their 80s are allowed to stay in their convent, but only if they quit social media. Their fight against Church authorities has captivated the world!
Discover the fascinating story behind Amazon's Fire Phone, a device packed with ambitious features that ultimately failed to capture users' hearts. Join us as we explore how this tech giant miscalculated its smartphone ambitions.
The sci-fi sequel 'Predator: Badlands' opens at the top of the box office with $15.6 million, outperforming expectations, while other notable releases struggle to gain traction.
Discover how a Philadelphia graphic designer drew inspiration from diverse cultures to craft the striking visuals for Zohran Mamdani's groundbreaking campaign, which has sparked conversations in Jewish Democratic politics.
With the fantasy football playoffs approaching, discover the must-start players and those to avoid in Week 10. Key insights on quarterbacks, running backs, receivers, and tight ends that could make or break your season!
A supermoon is causing king tides and coastal flooding in California as a powerful storm hits Northern regions. Dangerous rip currents and flooding are expected along the coast, prompting emergency warnings.
In a groundbreaking move, President Trump announces deals with Eli Lilly and Novo Nordisk to reduce obesity drug prices, making treatments more accessible for millions of Americans. Medicare coverage for GLP-1 drugs starts in 2026, changing the landscape of obesity treatment.